UCHealth Interstitial Lung Disease Clinic - Anschutz Medical Campus

Home Locations UCHealth Interstitial Lung Disease Clinic - Anschutz Medical Campus

Before visiting someone,
please read our visitation policy to help with the planning of your visit.

Monday: 8am – 4:30pm
Tuesday: 8am – 4:30pm
Wednesday: 8am – 4:30pm
Thursday: 8am – 4:30pm
Friday: 8am – 4:30pm
Saturday: Closed
Sunday: Closed
Your team
Fred McLafferty, MD
View Profile
Pulmonary Disease

Natalie Held, MD
View Profile
Pulmonary Disease

Jenny Williams, PA
View Profile
Pulmonary Disease and Critical Care Medicine

Bridget Graney, MD
View Profile
Pulmonary Disease

Joyce Lee, MD
View Profile
Pulmonary Disease

View all 6 providers

Best Hospitals badge pulmonology & lung surgeryExperts in treating interstitial lung disease

Our entire team at the Interstitial Lung Disease (ILD) clinic is dedicated to improving the lives of our patients with ILD through patient care, education and research.

Our multidisciplinary team combines the skills of pulmonologists, rheumatologists, thoracic radiologists and thoracic pathologists, all of whom have specific expertise in ILD and work closely with subspecialists, including the lung transplant team.

A Pulmonary Fibrosis Foundation Care Center

UCHealth University of Colorado Hospital is designated as a Pulmonary Fibrosis (PF) Foundation Care Center network site.

PF Care Centers have the necessary resources and specialized staff to fully manage pulmonary fibrosis, and use a multidisciplinary approach to provide the most comprehensive patient care. Experts in pulmonology, rheumatology, radiology, pathology and nursing specializing in interstitial lung disease comprise the care team at each PF Care Center.

Our care approach

Interstitial lung diseases vary greatly, but all of them involve scarring and inflammation in the lung. Our collaborative team is here to treat all of those medical conditions. We offer a comprehensive and personalized approach to your care, including:

  • Diagnosis.
  • Prognosis.
  • Genetic risk assessment.
  • Treatment, including novel antifibrotic therapy.
  • Symptom management.
  • Clinical trials (testing of new therapies).
  • Education and support resources.
  • Pulmonary rehabilitation services.
  • Communication with providers to ensure continuity of care.
  • Lung transplantation through the only program in the state.

We also provide unique expertise in a broad range of ILD and related respiratory diseases, including:

  • Automimmune-related ILD.
  • Familial pulmonary fibrosis.
  • Hypersensitivity pneumonitis.
  • Idiopathic pulmonary fibrosis.
  • Lymphangioleiomyomatosis.
  • Organizing pneumonia.
  • Rheumatoid arthritis-associated ILD.
  • Sarcoidosis.
  • Scleroderma.

Clinical trials

Patients with lung and respiratory conditions have the opportunity to enroll in clinical trials, which aim to improve treatment protocols and patient outcomes.

Visit our clinical trials page

Videos from our providers